GSTM1 and head and neck squamous cell carcinoma: Numerous studies have demonstrated that low hemoglobin (Hb) is a strong prognostic indicator of poor disease control and survival in patients with head and neck squamous cell carcinomas (HNSCC) 1, 2, 3.